Cargando…
The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells
BACKGROUND: The lack of drug targets is an obstacle to the treatment of patients with triple-negative breast cancer (TNBC). At present, non-specific cytotoxic drugs are first-line agents, but the development of resistance is a major problem with these agents. The epidermal growth factor receptor (EG...
Autores principales: | Tam, Stanton, Al-Zubaidi, Yassir, Rahman, Md Khalilur, Bourget, Kirsi, Zhou, Fanfan, Murray, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584993/ https://www.ncbi.nlm.nih.gov/pubmed/35908023 http://dx.doi.org/10.1007/s43440-022-00396-7 |
Ejemplares similares
-
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
por: Czarnomysy, Robert, et al.
Publicado: (2016) -
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010) -
Synergistic Effect of Squalene and Hydroxytyrosol on Highly Invasive MDA-MB-231 Breast Cancer Cells
por: Sánchez-Quesada, Cristina, et al.
Publicado: (2022) -
Loquat (Eriobotrya japonica) leaf extract inhibits the growth of MDA-MB-231 tumors in nude mouse xenografts and invasion of MDA-MB-231 cells
por: You, Mi-Kyoung, et al.
Publicado: (2016) -
Effects of combination therapy of docetaxel with selenium on the human breast cancer cell lines MDA-MB-231 and MCF-7
por: Park, Sang O, et al.
Publicado: (2015)